What Are the Market Size Estimates and Growth Rates for Egrifta (Tesamorelin Acetate) Global Market?
The egrifta (tesamorelin acetate) market size has seen notable growth in recent years and will continue to expand from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth is primarily due to increasing awareness of HIV-related complications, rising demand for drug therapy, increasing use of antiretroviral therapy, growing focus on quality of life, advances in medical research, and awareness.
It is anticipated that the egrifta (tesamorelin acetate) market size will see further growth in the coming years, reaching $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. This growth can be attributed to the increasing prevalence of chronic diseases, rise in hospitals, rising demand for advanced body health monitoring tools, the increasing prevalence of metabolic disorders, and rising awareness for disease treatment. Major trends in the forecast period include increasing adoption of targeted treatments, integration with comprehensive care plans, growth in personalized medicine, enhanced patient support programs, and rising research activities.
Get Your Free Sample of The Global Egrifta (Tesamorelin Acetate) Global Market Report 2025 Report
https://www.thebusinessresearchcompany.com/sample_request?id=20043&type=smp
What’s Driving Egrifta (Tesamorelin Acetate) Global Market Growth?
The driving factor for the future growth of the egrifta (tesamorelin acetate) market is the increasing prevalence of human immunodeficiency virus (HIV) cases. HIV weakens an individual’s immune system, and its rising incidence can be partially attributed to insufficient awareness and education about preventive measures, especially among high-risk groups. Egrifta helps improve the overall health and quality of life for HIV patients by stimulating the release of the growth hormone to decrease excess visceral fat and improve body composition. The Minnesota Department of Health reported 324 new HIV diagnoses in 2023, a 24% increase from 2022.
What Are the Key Market Segments in the Global Egrifta (Tesamorelin Acetate) Market?
1) By Clinical Indication: Human Immunodeficiency Virus (HIV)-Associated Lipodystrophy, Growth Hormone Deficiency, Abdominal Obesity, Metabolic Syndrome
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By End-Users: Hospitals, Specialized Clinics, Home Care
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/egrifta-tesamorelin-acetate-global-market-report
Who Are the Key Players in the Egrifta (Tesamorelin Acetate) Global Market?
The major players in the egrifta (tesamorelin acetate) market include Theratechnologies Inc.
What Are the Key Trends in the Egrifta (Tesamorelin Acetate) Global Market?
One of the major trends in the egrifta (tesamorelin acetate) market is the focus on developing advanced synthetic peptide drugs to enhance the effectiveness of treatments for HIV-related lipodystrophy. Synthetic peptide drugs are designed to deliver specific therapeutic effects by mimicking or enhancing the action of naturally occurring peptides. Theratechnologies Inc. announced in December 2024 that production of EGRIFTA SV has resumed following a voluntary shutdown due to FDA inspection observations.
Which Region Holds the Largest Market Share in the Egrifta (Tesamorelin Acetate) Global Market?
North America was the largest region in the egrifta (tesamorelin acetate) market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period.
What Does The Egrifta (Tesamorelin Acetate) Global Market Report 2025 Offer?
Egrifta (tesamorelin acetate) is a synthetic peptide that reduces excess abdominal fat by stimulating growth hormone release in HIV patients with lipodystrophy. By promoting fat breakdown, it improves fat distribution and minimizes health risks associated with abdominal fat. The Global Egrifta (Tesamorelin Acetate) Market Report 2025 research from The Business Research Company provides global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights.
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20043
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead by contacting us via:
Europe : +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
